The Rise and Fall of Needelman Asset Management's Q2 2018 vs. Q3 2018 Holdings

In the fast-paced world of finance, everything can change in a matter of seconds. This is particularly true for fund managers who continuously monitor and adjust their holdings to maximize profitability. One such firm is Needelman Asset Management Inc, which recently filed its 13F for Q2 2018 vs. Q3 2018. In this article, we delve into the changes made by Needelman Asset Management and analyze the ramifications of these moves.

Needelman Asset Management made significant adjustments to its portfolio by selling off its entire stake in some of the most recognizable companies. In Q2 2018, the firm held 63,656 shares of Wells Fargo & Co, worth $3.5 million, but by Q3 2018, the firm had completely divested itself of the company. The same was true for Rio Tinto PLC, Microsoft Corp, International Business Machine (IBM), AT&T Inc, Gilead Sciences Inc, UnitedHealth Group Inc, Intel Corporation, Bank of America Corp, JPMorgan Chase & Co, Anthem Inc, Fluor Corp, Markel Corp, Honeywell International Inc, Berkshire Hathaway Inc Class B, Nestle SA Spnsrd Adr Rep Rg Sh, Diageo PLC, Abbvie Inc, Abbott Laboratories, Kimberly Clark, Chevron Corp New, Johnson & Johnson, Emerson Electric Company, Pfizer Inc, Apple Inc, AON PLC Class A, Chubb Limited, NCR Corp, Qualcomm Inc, Procter and Gamble Company, Verizon Communications, Bristol-Myers Squibb Co, Mondelez International Inc, and Kraft Heinz Company. This selling spree might have shocked some observers, but Needelman Asset Management also made notable purchases during the same period.

The firm amassed more than 1 million shares of VMware Inc. in Q3 2018, worth over $140 million, making it the company's largest holding. The firm also increased its stake in EOG Resources Inc, an oil and gas exploration company, by 1500%. The firm now holds 33,330 shares of EOG Resources, worth $4.2 million. In addition, the firm initiated a position in Southern Company, purchasing 50,000 shares, valued at roughly $2.5 million. The firm's other notable purchases during the period include Teladoc Health Inc, Twilio Inc, and DocuSign Inc.

Although it's not altogether uncommon for fund managers to sell off holdings from time to time to make room for new additions, such widespread selling is a cause for concern. Observers are interpreting the move as a signal that Needelman Asset Management could be bearish on the market and preparing for a potential downturn. However, it's worth noting that there may be other reasons behind the shift in strategy, such as changes in management or modifications to the firm's risk tolerance. Regardless, the sudden selling spree on such massive holdings will have some effect on the market.

In conclusion, Needelman Asset Management's Q2 2018 vs. Q3 2018 13F filings show that the firm sold off significant stakes in several recognizable companies while amassing shares in some newer players. The motivations behind these moves are difficult to determine, but observers are suggesting that the shift in strategy might be due to several factors, including market uncertainty or changes in risk tolerance. Whatever the reason might be, the market will undoubtedly react to such a widespread change in holdings, and only time will tell whether Needelman Asset Management's recent moves will pay off.